ATLAS-studien – en klinisk stgnudie för personer som vill bidra till forskningen kring SOD1 i samband med ALS
Biogen genomför en klinisk studie för att bedöma effektiviteten och säkerheten hos…
![Håll [u]kontakten[/u]](/static/paper-plane.svg)
Food and Drug Administration (FDA) godkänner AMX0035 (Amylyx) för den amerikanska marknaden
Under ett möte i FDAs rådgivande kommitté för perifera och centrala nervsystemet…
Measuring treatment effects based on patient preference
To evaluate the effect of an investigational drug in ALS clinical trials,…
TRICALS Enrols First Participants in Phase 3 MAGNET platform trial for ALS
TRICALS (the Treatment Research Initiative to Cure ALS), in collaboration with ALS…
USA: new law promises $100 million for ALS research
A new law has been passed in the United States to give…
Congratulations to our TRICALS colleagues as UK Government invests £50 million to find a cure for ALS
The UK government has recently announced that £50 million will be invested…
A road map for digital health care technology in MND
The COVID-19 pandemic has had an important impact on the development and…
Amylyx Pharmaceuticals and TRICALS to collaborate on phase 3 clinical trial
Today, Amylyx Pharmaceuticals provided an update on its plans to advance its…
Newsletter December 2020
2020 has been a difficult year for everyone. However, despite the many…